206 results on '"Jonathan Berg"'
Search Results
2. P157: Willing but not (quite) ready: Primary care provider perspectives on expanded genetic screening in children
- Author
-
Elizabeth Branch, Neal deJong, Samantha Schilling, Jonathan Berg, Laura Milko, Sabrina Powell, Ann Katherine Foreman, Megan Roberts, and Katrina Donahue
- Subjects
Genetics ,QH426-470 ,Medicine - Published
- 2024
- Full Text
- View/download PDF
3. P155: The ClinGen framework for naming monogenic diseases
- Author
-
Courtney Thaxton, Leslie Biesecker, Marina DiStefano, Melissa Haendel, Emma Owens, Ada Hamosh, Sharon Plon, Heidi Rehm, and Jonathan Berg
- Subjects
Genetics ,QH426-470 ,Medicine - Published
- 2024
- Full Text
- View/download PDF
4. P530: Point-of-care genetic testing with paired E-consult: An effective alternative service delivery model for patients with breast cancer
- Author
-
Christine Kobelka, Jonathan Berg, Julianne O'Daniel, Kimberly Foss, Ashlynn Messmore, Bradford Powell, Erica Baynard, and Megan Roberts
- Subjects
Genetics ,QH426-470 ,Medicine - Published
- 2024
- Full Text
- View/download PDF
5. P563: With great panels comes great responsibility: In pursuit of a well-evidenced age-based genomic screen
- Author
-
Ann Katherine Foreman, Jahnelle Jackson, Laura Milko, Elizabeth Branch, Neal deJong, Heidi Cope, Jessica Hunter, Elizabeth Jalazo, Julianne O'Daniel, Holly Peay, Bradford Powell, Cynthia Powell, and Jonathan Berg
- Subjects
Genetics ,QH426-470 ,Medicine - Published
- 2024
- Full Text
- View/download PDF
6. P570: Generating a framework for curating mechanism of disease in monogenic conditions: A consensus effort of the Gene Curation Coalition
- Author
-
Marina DiStefano, Fowzan Alkuraya, Joanna Amberger, Christina Austin-Tse, Ola Austine, Marie Balzotti, Jonathan Berg, Elspeth Bruford, Alicia Byrne, Elena Cibrian-Uhalte, Alison Coffey, Helen Firth, Ada Hamosh, Sarah Hunt, Teri Klein, Catherine Kurtz, Sarah Leigh, Ivone Leong, Caterina Lucano, Sateesh Maddirevula, Audrey O'Neill, Arina Puzriakova, Ana Rath, Angharad Roberts, Kelly Radtke, Erin Ramos, Erin Riggs, Charlotte Rodwell, Julie Taylor, Katrin Sangkuhl, Catherine Snow, Zornitza Stark, James Ware, Bess Wayburn, Phillip Weller, and Heidi Rehm
- Subjects
Genetics ,QH426-470 ,Medicine - Published
- 2024
- Full Text
- View/download PDF
7. O40: UNC EDGE: An undergraduate genomics experience to foster diversity in genomics
- Author
-
Sabrina Powell, Grace Byfield, Kelly Fraidenburg, Terry Furey, Bradford Powell, Dawayne Whittington, Jonathan Berg, and Folami Ideraabdullah
- Subjects
Genetics ,QH426-470 ,Medicine - Published
- 2024
- Full Text
- View/download PDF
8. P877: Understanding the advantages of translating educational materials for the Clinical Genome Resource
- Author
-
Ineke Cordova, Zo Bly, Jonathan Berg, Joanna Bulkley, Marina DiStefano, Teri Klein, Joannella Morales, Deborah Ritter, and Erin Riggs
- Subjects
Genetics ,QH426-470 ,Medicine - Published
- 2024
- Full Text
- View/download PDF
9. Melanin: a unifying theory of disease as exemplified by Parkinson’s, Alzheimer’s, and Lewy body dementia
- Author
-
Stacie Z. Berg and Jonathan Berg
- Subjects
Parkinson’s disease ,Lewy body dementia ,Alzheimer’s disease ,melanin ,glyphosate ,inflammation ,Immunologic diseases. Allergy ,RC581-607 - Abstract
Melanin, a ubiquitous dark pigment, plays important roles in the immune system, including scavenging reactive oxygen species formed in response to ultraviolet radiation absorption, absorbing metals, thermal regulation, drug uptake, innate immune system functions, redox, and energy transduction. Many tissue types, including brain, heart, arteries, ovaries, and others, contain melanin. Almost all cells contain precursors to melanin. A growing number of diseases in which there is a loss of melanin and/or neuromelanin are increasingly thought to have infectious etiologies, for example, Alzheimer’s disease (AD), Parkinson’s disease (PD), Lewy Body Dementia (LBD), and vitiligo. AD, PD, LBD, and vitiligo have been linked with herpesvirus, which enters melanosomes and causes apoptosis, and with gut dysbiosis and inflammation. Herpesvirus is also linked with gut dysbiosis and inflammation. We theorize that under normal healthy states, melanin retains some of the energy it absorbs from electromagnetic radiation, which is then used to fuel cells, and energy from ATP is used to compliment that energy supply. We further theorize that loss of melanin reduces the energy supply of cells, which in the case of AD, PD, and LBD results in an inability to sustain immune system defenses and remove the plaques associated with the disease, which appear to be part of the immune system’s attempt to eradicate the pathogens seen in these neurodegenerative diseases. In addition, in an attempt to explain why removing these plaques does not result in improvements in cognition and mood and why cognitions and moods in these individuals have ebbs and flows, we postulate that it is not the plaques that cause the cognitive symptoms but, rather, inflammation in the brain resulting from the immune system's response to pathogens. Our theory that energy retained in melanin fuels cells in an inverse relationship with ATP is supported by studies showing alterations in ATP production in relationship to melanin levels in melanomas, vitiligo, and healthy cells. Therefore, alteration of melanin levels may be at the core of many diseases. We propose regulating melanin levels may offer new avenues for treatment development.
- Published
- 2023
- Full Text
- View/download PDF
10. Development and initial testing of a multi-stakeholder intervention for Lynch syndrome cascade screening: an intervention mapping approach
- Author
-
Lauren Passero, Swetha Srinivasan, Mary E. Grewe, Jennifer Leeman, Jonathan Berg, Daniel Reuland, and Megan C. Roberts
- Subjects
Lynch syndrome ,Intervention design ,Intervention mapping ,Cascade screening ,Usability testing ,Public aspects of medicine ,RA1-1270 - Abstract
Abstract Background Lynch syndrome is an underdiagnosed hereditary condition carrying an increased lifetime risk for colorectal and endometrial cancer and affecting nearly 1 million people in the United States. Cascade screening, systematic screening through family members of affected patients, could improve identification of Lynch syndrome, but this strategy is underused due to multi-level barriers including low knowledge about Lynch syndrome, low access to genetics services, and challenging family dynamics. Methods We used intervention mapping, a 6-step methodology to create stakeholder-driven interventions that meet the needs of a target population, to develop an intervention to improve cascade screening for Lynch syndrome. The intervention development process was guided by input from key stakeholders in Lynch syndrome care and patients. We conducted usability testing on the intervention with Lynch syndrome patients using qualitative semi-structured interviewing and rapid qualitative analysis. Results We developed a workbook intervention named Let’s Talk that addresses gaps in knowledge, skills, self-efficacy, outcome expectancy and other perceived barriers to cascade screening for Lynch syndrome. Let’s Talk contained educational content, goal setting activities, communication planning prompts and supplemental resources for patients to plan family communication. Evidence-based methods used in the workbook included information chunking, guided practice, goal setting and gain-framing. We conducted usability testing focused on the complexity and relative advantage of the intervention through 45-min virtual interviews with 10 adult patients with Lynch syndrome recruited from a national advocacy organization in the United States. Usability testing results suggested the intervention was acceptable in terms of complexity and relative advantage to other available resources, but additional information for communication with young or distant family members and a web-based platform could enhance the intervention’s usability. Conclusions Intervention mapping provided a framework for intervention development that addressed the unique needs of Lynch syndrome patients in overcoming barriers to cascade screening. Future work is needed to transform Let’s Talk into a web-based tool and evaluate the effectiveness of the intervention in clinical practice with patients and genetic counselors. Intervention mapping can be useful to researchers as an evidence-based technique to develop stakeholder-centered interventions for addressing the needs of other unique populations.
- Published
- 2022
- Full Text
- View/download PDF
11. Ventricular longitudinal function by cardiovascular magnetic resonance predicts cardiovascular morbidity in HFrEF patients
- Author
-
Jonathan Berg, Julius Åkesson, Robert Jablonowski, Kristian Solem, Einar Heiberg, Rasmus Borgquist, Håkan Arheden, and Marcus Carlsson
- Subjects
Heart failure ,Magnetic resonance imaging ,Mortality/survival ,Contractile function ,Diseases of the circulatory (Cardiovascular) system ,RC666-701 - Abstract
Abstract Aims Ventricular longitudinal function measured as basal‐apical atrioventricular plane displacement (AVPD) or global longitudinal strain (GLS) is a potent predictor of mortality and could potentially be a predictor of heart failure‐associated morbidity. We hypothesized that low AVPD and GLS are associated with the combined endpoint of cardiovascular mortality and heart failure‐associated morbidity. Methods and results Two hundred eighty‐seven patients (age 62 ± 12 years, 78% male) with heart failure with reduced (≤40%) ejection fraction (HFrEF) referred to a cardiovascular magnetic resonance exam were included. Ventricular longitudinal function, ventricular volume, and myocardial fibrosis or infarction were analysed from cine and late gadolinium enhancement images. National registries provided data on causes of cardiovascular hospitalizations and cardiovascular mortality for the combined endpoint. Time‐to‐event analysis capable of including reoccurring events was employed with a 5‐year follow‐up. HFrEF patients had EF 26.5 ± 8.0%, AVPD 7.8 ± 2.4 mm, and GLS −7.5 ± 3.0%. In contrast, ventricular longitudinal function was approximately twice as large in an age‐matched control group (AVPD 15.3 ± 1.6 mm; GLS −20.6 ± 2.0%; P −6.1%) overall experienced more than 3 times as many events as the top tertile (>8.8 mm or
- Published
- 2022
- Full Text
- View/download PDF
12. Incremental Value of Exercise ECG to Myocardial Perfusion Single‐Photon Emission Computed Tomography for Prediction of Cardiac Events
- Author
-
Morten Kraen, Shahnaz Akil, Bo Hedén, Jonathan Berg, Ellen Ostenfeld, Marcus Carlsson, Håkan Arheden, and Henrik Engblom
- Subjects
exercise ECG ,MPI ,MPS ,myocardial perfusion SPECT ,prognosis ,SPECT ,Diseases of the circulatory (Cardiovascular) system ,RC666-701 - Abstract
Background Both myocardial perfusion single‐photon emission computed tomography (MPS) and exercise ECG (Ex‐ECG) carry prognostic information in patients with stable chest pain. However, it is not fully understood if combining the findings of MPS and Ex‐ECG improves risk prediction. Current guidelines no longer recommend Ex‐ECG for diagnostic evaluation of chronic coronary syndrome, but Ex‐ECG could still be of incremental prognostic importance. Methods and Results This study comprised 908 consecutive patients (age 63.3±9.4 years, 49% male) who performed MPS with Ex‐ECG. Subjects were followed for 5 years. The end point was a composite of cardiovascular death, acute myocardial infarction, unstable angina, and unplanned percutaneous coronary intervention. National registry data and medical charts were used for end point allocation. Combining the findings of MPS and Ex‐ECG resulted in concordant evidence of ischemia in 72 patients or absence of ischemia in 634 patients. Discordant results were found in 202 patients (MPS−/Ex‐ECG+, n=126 and MPS+/Ex‐ECG−, n=76). During follow‐up, 95 events occurred. Annualized event rates significantly increased across groups (MPS−/Ex‐ECG− =1.3%, MPS−/Ex‐ECG+ =3.0%, MPS+/Ex‐ECG− =5.1% and MPS+/Ex‐ECG+ =8.0%). In multivariable analyses MPS was the strongest predictor regardless of Ex‐ECG findings (MPS+/Ex‐ECG−, hazard ratio [HR], 3.0, P=0.001 or MPS+/Ex‐ECG+, HR,4.0, P
- Published
- 2023
- Full Text
- View/download PDF
13. P376: Co-designing genetics and genomics educational modules for community engagement
- Author
-
Grace Byfield, Sabrina Powell, Daniel Torres, Jahnelle Jackson, Langston Harrison, Andreas Orphanides, Ken Ray, Erin James-Crook, Thomas Owens, Jonathan Shaw, Larry Bradon, Heather Osborne, Julianne O'Daniel, Jonathan Berg, and Laura Milko
- Subjects
Genetics ,QH426-470 ,Medicine - Published
- 2023
- Full Text
- View/download PDF
14. P379: Characterizing research on the diagnostic odyssey in the United States: A systematic mapping review
- Author
-
Hannah Margaret Clare, Margaret Waltz, Jonathan Berg, Bradford Powell, Michael Adams, Anna Kahkoska, and Kristen Hassmiller Lich
- Subjects
Genetics ,QH426-470 ,Medicine - Published
- 2023
- Full Text
- View/download PDF
15. P451: The Gene Curation Coalition works to resolve discrepancies in gene-disease validity assertions
- Author
-
Marina DiStefano, Joanna Amberger, Christina Austin-Tse, Marie Balzotti, Mutaz Amin, Jonathan Berg, Carol Bocchini, Elspeth Bruford, Fowzan Alkuraya, Alison Coffey, Heather Collins, Fiona Cunningham, Helen Firth, David Fitzpatrick, Yaron Einhorn, Jennifer Goldstein, Ada Hamosh, Sarah Leigh, Ivone Leong, Christa Martin, Ellen McDonagh, Arina Puzriakova, Ana Rath, Angharad Roberts, Kelly Radtke, Erin Ramos, Erin Riggs, Charlotte Rodwell, Katrin Sangkuhl, Catherine Snow, Zornitza Stark, Jackie Tahiliani, James Ware, Eleanor Williams, Caroline Wright, Michael Yates, Phillip Weller, and Heidi Rehm
- Subjects
Genetics ,QH426-470 ,Medicine - Published
- 2023
- Full Text
- View/download PDF
16. P694: UNC EDGE Genomics: A new undergraduate training program to increase inclusion in the genomics workforce
- Author
-
Sabrina Powell, Grace Byfield, Kelly Fraidenburg, Terry Furey, Gail Henderson, Bradford Powell, Dawayne Whittington, Jonathan Berg, and Folami Ideraabdullah
- Subjects
Genetics ,QH426-470 ,Medicine - Published
- 2023
- Full Text
- View/download PDF
17. PERIOD 2 regulates low-dose radioprotection via PER2/pGSK3β/β-catenin/Per2 loop
- Author
-
Aris T. Alexandrou, Yixin Duan, Shanxiu Xu, Clifford Tepper, Ming Fan, Jason Tang, Jonathan Berg, Wassim Basheer, Tyler Valicenti, Paul F. Wilson, Matthew A. Coleman, Andrew T. Vaughan, Loning Fu, David J. Grdina, Jefferey Murley, Aijun Wang, Gayle Woloschak, and Jian Jian Li
- Subjects
Biological sciences ,cell biology ,molecular biology ,Science - Abstract
Summary: During evolution, humans are acclimatized to the stresses of natural radiation and circadian rhythmicity. Radiosensitivity of mammalian cells varies in the circadian period and adaptive radioprotection can be induced by pre-exposure to low-level radiation (LDR). It is unclear, however, if clock proteins participate in signaling LDR radioprotection. Herein, we demonstrate that radiosensitivity is increased in mice with the deficient Period 2 gene (Per2def) due to impaired DNA repair and mitochondrial function in progenitor bone marrow hematopoietic stem cells and monocytes. Per2 induction and radioprotection are also identified in LDR-treated Per2wt mouse cells and in human skin (HK18) and breast (MCF-10A) epithelial cells. LDR-boosted PER2 interacts with pGSK3β(S9) which activates β-catenin and the LEF/TCF mediated gene transcription including Per2 and genes involved in DNA repair and mitochondrial functions. This study demonstrates that PER2 plays an active role in LDR adaptive radioprotection via PER2/pGSK3β/β-catenin/Per2 loop, a potential target for protecting normal cells from radiation injury.
- Published
- 2022
- Full Text
- View/download PDF
18. Physiological and Perceptual Responses to Single-player vs. Multiplayer Exergaming
- Author
-
Aarón Soria Campo, Alf Inge Wang, Trine Moholdt, and Jonathan Berg
- Subjects
active video game ,cardiorespiratory fitness ,exercise training ,fitness ,gamification ,health technology ,Sports ,GV557-1198.995 - Abstract
RationaleSince many modern exergames include a multiplayer component, this study aimed to compare the physiological and perceptual responses between playing a cycling exergame alone or with others.MethodsIn this randomized crossover study, 15 healthy individuals aged between 10 and 30 years completed a single-player and a multiplayer exergaming session. The main outcomes were exercise intensity, measured as oxygen uptake (V°O2) and heart rate (HR), and perceived enjoyment, pleasure, and exertion.ResultsPeak HR was significantly higher during multiplayer (172 ± 23 beats per minute [bpm]) vs. single-player exergaming (159 ± 27 bpm) with a mean difference of 13 bpm (95% CI: 2 to 24, p = 0.02). Peak V°O2 was 33.6 ± 9.5 mL·kg−1·min−1 and 30.4 ± 9.1 mL·kg−1·min−1 during multiplayer and single-player exergaming, respectively with no statistically significant difference between conditions (3.2, 95% CI: −0.2–6.6 mL·kg−1·min−1, p = 0.06). Average HR, average V°O2 and perceptual responses did not differ between single- and multiplayer exergaming.ConclusionOther than inducing a higher HR, multiplayer exergaming showed no significant benefits on exercise intensity or perceptual responses over single-player exergaming. However, the higher peak HR and a tendency of higher peak V°O2 intensity during multiplayer exergaming imply that multiplayer exergaming may offer some advantages over single-player exergaming that could impact the potential health benefits of exergaming.
- Published
- 2022
- Full Text
- View/download PDF
19. Recommendations for the collection and use of multiplexed functional data for clinical variant interpretation
- Author
-
Hannah Gelman, Jennifer N. Dines, Jonathan Berg, Alice H. Berger, Sarah Brnich, Fuki M. Hisama, Richard G. James, Alan F. Rubin, Jay Shendure, Brian Shirts, Douglas M. Fowler, Lea M. Starita, and On behalf of the Brotman Baty Institute Mutational Scanning Working Group
- Subjects
Medicine ,Genetics ,QH426-470 - Abstract
Abstract Variants of uncertain significance represent a massive challenge to medical genetics. Multiplexed functional assays, in which the functional effects of thousands of genomic variants are assessed simultaneously, are increasingly generating data that can be used as additional evidence for or against variant pathogenicity. Such assays have the potential to resolve variants of uncertain significance, thereby increasing the clinical utility of genomic testing. Existing standards from the American College of Medical Genetics and Genomics (ACMG)/Association for Molecular Pathology (AMP) and new guidelines from the Clinical Genome Resource (ClinGen) establish the role of functional data in variant interpretation, but do not address the specific challenges or advantages of using functional data derived from multiplexed assays. Here, we build on these existing guidelines to provide recommendations to experimentalists for the production and reporting of multiplexed functional data and to clinicians for the evaluation and use of such data. By following these recommendations, experimentalists can produce transparent, complete, and well-validated datasets that are primed for clinical uptake. Our recommendations to clinicians and diagnostic labs on how to evaluate the quality of multiplexed functional datasets, and how different datasets could be incorporated into the ACMG/AMP variant-interpretation framework, will hopefully clarify whether and how such data should be used. The recommendations that we provide are designed to enhance the quality and utility of multiplexed functional data, and to promote their judicious use.
- Published
- 2019
- Full Text
- View/download PDF
20. ‘We have been in lockdown since he was born’: a mixed methods exploration of the experiences of families caring for children with intellectual disability during the COVID-19 pandemic in the UK
- Author
-
Diana Baralle, Susan Walker, Ramya Srinivasan, Shelagh Joss, Jonathan Berg, Miranda Splitt, Usha Kini, Pradeep Vasudevan, John Dean, Yanick Crow, Beverly Searle, Julian Barwell, Lyn Chitty, Peter Holmans, Sarah Law, Virginia Clowes, Rachel Harrison, Muriel Holder, Sahar Mansour, Spiros Denaxas, Ellie Kerry, Frances Flinter, Zheng Ye, Julia Rankin, Oliver Quarrell, Nicola Lewis, Anne Lampe, Astrid Weber, David Skuse, Kate Baker, Annie Procter, Jeremy Hall, Alison Kraus, Neil Walker, Jeanne Wolstencroft, Laura Hull, Lauren Warner, Tooba Nadeem Akhtar, William Mandy, Eleanor Dewhurst, Amy Lafont, F Lucy Raymond, Terry Shirley, Hayley Tilley, Husne Timur, Catherine Titterton, Sarah Wallwork, Francesca Wicks, Marie Erwood, Sophie Andrews, Philippa Birch, Samantha Bowen, Karen Bradley, Aimee Challenger, Samuel Chawner, Andrew Cuthbert, Sinead Morrison, Hayley Moss, Michael Owen, Sinead Ray, Matthew Sopp, Molly Tong, Marianne van den Bree, Nadia Coscini, Hayley Denyer, Nasrtullah Fatih, Manoj Juj, Anna Lucock, Frida Printzlau, Alice Watkins, Anna Pelling, Lisa Robertson, Denise Williams Alan, Donaldson Lucy, and Fleur van Dijk
- Subjects
Medicine - Published
- 2021
- Full Text
- View/download PDF
21. Creation and Worldwide Utilisation of New COVID-19 Online Information Hub for Genetics Health Professionals, Patients and Families
- Author
-
Adam P. Tobias, Jonathan Berg, Roseanne Cetnarskyj, Zosia Miedzybrodzka, Mary E. Porteous, and Edward S. Tobias
- Subjects
COVID–19 ,online ,genetics ,education ,coronavirus ,genomics ,Genetics ,QH426-470 - Abstract
The current COVID-19 pandemic has unfortunately resulted in many significant concerns for individuals with genetic disorders and their relatives, regarding the viral infection and, particularly, its specific implications and additional advisable precautions for individuals affected by genetic disorders. To address this, the resulting requirement for guidance and information for the public and for genetics professionals was discussed among colleagues nationally, on the ScotGEN Steering Committee, and internationally on the Education Committee of the European Society of Human Genetics (ESHG). It was agreed that the creation of an online hub of genetics-related COVID-19 information resources would be particularly helpful. The proposed content, divided into a web page for professionals and a page for patients, was discussed with, and approved by, genetics professionals. The hub was created and provided online at www.scotgen.org.uk and linked from the ESHG’s educational website for genetics and genomics, at www.eurogems.org. The new hub provides links, summary information and representative illustrations for a wide range of selected international resources. The resources for professionals include: COVID-19 research related hubs provided by Nature, Science, Frontiers, and PubMed; clinical guidelines; the European Centre for Disease Prevention and Control; the World Health Organisation; and molecular data sources including coronavirus 3D protein structures. The resources for patients and families include links to many accessible sources of support and relevant information. Since the launch of the pages, the website has received visits from over 50 countries worldwide. Several genetics consultants have commented on usefulness, clarity, readability, and ease of navigation. Visits have originated most frequently in the United Kingdom, Kuwait, Hong Kong, Moldova, United States, Philippines, France, and Qatar. More links have been added since the launch of the hub to include additional international public health and academic resources. In conclusion, an up-to-date online hub has been created and made freely available for healthcare professionals, patients, relatives and the public, providing categorised easily navigated links to a range of worldwide resources related to COVID-19. These pages are receiving a rapidly growing number of return visits and the authors continue to maintain and update the pages’ content, incorporating new developments in this field of enormous worldwide importance.
- Published
- 2021
- Full Text
- View/download PDF
22. Can Gaming Get You Fit?
- Author
-
Jonathan Berg, Alf Inge Wang, Stian Lydersen, and Trine Moholdt
- Subjects
active video games ,cardiorespiratory fitness ,exercise training ,gamification ,high-intensity interval training ,physical activity ,Physiology ,QP1-981 - Abstract
RationaleExergaming may be a viable alternative to more traditional exercise. As high-intensity exercise can provide substantial health benefits, the purpose of this study was to investigate the long-term effectiveness of providing inactive adults with access to a high-intensity exergaming platform.MethodsIn this study, 52 inactive adults (
- Published
- 2020
- Full Text
- View/download PDF
23. Game on: a cycling exergame can elicit moderate-to-vigorous intensity. A pilot study
- Author
-
Jonathan Berg
- Subjects
Medicine (General) ,R5-920 - Abstract
ObjectivesThe aims of this pilot study were to investigate oxygen uptake (V̇O2) while playing a cycling exergame to assess exercise intensity to determine its potential as a feasible exercise alternative to improve aerobic fitness, and to assess the validity of using heart rate (HR) to estimate V̇O2 in exergaming.MethodsFive males (age: 32±8; peak oxygen uptake (V̇O2peak): 47.9±7.8 mL·kg−1·min−1) and five females (age: 27±3; V̇O2peak: 33.9±4.6 mL·kg−1·min−1) played the cycling exergame ‘Pedal Tanks’ for 45 min, with measurements of HR and V̇O2.ResultsAverage and peak V̇O2 during exergaming were 61.7±10.1% and 78.3±11.7% of V̇O2peak, respectively, whereas average and peak HR were 80.0±9.4% and 91.5%±6.7% of HRpeak. There was a strong positive correlation between V̇O2 and HR for all participants (p
- Published
- 2020
- Full Text
- View/download PDF
24. Comparison of Mitochondrial Respiration in M. triceps brachii and M. vastus lateralis Between Elite Cross-Country Skiers and Physically Active Controls
- Author
-
Jonathan Berg, Vidar Undebakke, Øystein Rasch-Halvorsen, Lars Aakerøy, Øyvind Sandbakk, and Arnt Erik Tjønna
- Subjects
cross-country skiing ,endurance athletes ,high-resolution respirometry ,mitochondria ,oxidative phosphorylation ,peak oxygen uptake ,Physiology ,QP1-981 - Abstract
RationaleThe main purposes of this study were to compare mitochondrial respiration in M. triceps brachii and M. vastus lateralis between elite cross-country (XC) skiers and physically active controls (CON), and to explore the associations between mitochondrial respiration in these muscles and peak oxygen uptake (V˙O2peak) in arm- and leg-dominant exercise modes.MethodsThirteen male elite XC skiers (age: 25 ± 4; peak oxygen uptake (V˙O2peak): 75.5 ± 4.2 mL⋅kg-1⋅min-1) and twelve CON (age: 26 ± 3; V˙O2peak: 57.2 ± 6.4 mL⋅kg-1⋅min-1) had microbiopsies taken from M. vastus lateralis and M. triceps brachii, which were analyzed for various measures of mitochondrial respiration using high-resolution respirometry. Thereafter, all participants tested V˙O2peak in both running (RUN) and upper body poling (UBP).ResultsXC skiers had generally higher mitochondrial respiration in M. triceps brachii compared to CON (P < 0.001), whereas no significant group-differences in mitochondrial respiration in M. vastus lateralis were revealed. XC skiers had higher mitochondrial respiration in M. triceps brachii compared to M. vastus lateralis (P = 0.005–0.058), whereas in CON, most mitochondrial respiration measures were higher in M. vastus lateralis than in M. triceps brachii (P < 0.01). When all athletes were pooled, there was a strong positive correlation between V˙O2peak in UBP and mitochondrial respiration in M. triceps brachii on several measures (P < 0.01), whereas no correlation was found for RUN.ConclusionThe higher mitochondrial respiration found in M. triceps brachii compared to M. vastus lateralis among our elite XC skiers demonstrates the potential for the arm muscles to adapt to aerobic endurance training. The opposite pattern found in CON, clearly showed lower mitochondrial respiration in M. triceps brachii compared to XC skiers, whereas respiration in M. vastus lateralis did not differ between groups. The strong positive correlation between mitochondrial respiration in M. triceps brachii and V˙O2peak in UBP indicate that arm muscles’ respiratory function may be a limiting factor for V˙O2peak in arm-dominant exercise modes.
- Published
- 2019
- Full Text
- View/download PDF
25. Ervaringen van schaamte en psychologisch lijden door voedselbankklanten
- Author
-
Hille Hoogland and Jonathan Berg
- Subjects
voedselbanken, voedselbankklanten, financiële problemen, emoties, schaamte, stigma, psychologisch lijden, armoede ,Sociology (General) ,HM401-1281 - Abstract
Experiences of shame and psychological suffering by foodbank clients Foodbanks have existed for over ten years in the Netherlands. They provide weekly food parcels to 94,000 households, according to the most recent figures published by the national Dutch food bank organization at the end of 2014. The national foodbank organizations set qualifying criteria for clients who wish to receive a food parcel on a weekly basis. Foodbanks in the Netherlands have different ways of distributing the food to their clients. In some foodbanks the clients need to stand in line and receive a pre-packaged food parcel. In other foodbanks, clients can choose which products they take home. The food is donated, which means that the contents of the food parcels vary in terms of both the amount of food that they contain and the type of food. Research shows that most clients of foodbanks in the Netherlands have a very low income and are in debt. International and Dutch studies show that many foodbank clients suffer from health problems and chronic diseases. Psychological problems are also common among foodbank clients.In this article we aim to provide an insight into the psychological suffering, shame and other emotions that foodbank clients can experience. The findings are based on qualitative research, which was completed as part of an external PhD research study. We analysed 45 in-depth interviews with foodbank clients. We also related our findings to the results of studies on foodbank clients as well as studies about shame and stigma in relation to poverty. In the Netherlands, few studies have been conducted about foodbanks and their users, and in international studies too, the perspective of foodbank clients is missing. Our study fills this gap by focusing on these actors’ point of view.For this research, we selected foodbank clients in Amsterdam based on quota sampling. We approached clients at the foodbank or by phone and conducted in-depth interviews with 18 men and 27 women. The interviews were transcribed verbatim and analysed in Atlas.ti by two researchers, using attribute and structural coding.Our results show that foodbank clients use a combination of different strategies to cope with living on tight budgets. Most of them save money on food, non-food and social activities. Another strategy is to ask for support from family or friends for money, clothing or food. Some respondents are almost completely dependent on gifts from friends and the food parcel and some also reported being restricted in their social life and having lost friends. We found that lack of money is related to psychological suffering: sleeplessness, stress, fear, panic, depression and feelings of sadness. The causes mentioned for this suffering were: debts, persistent letters from creditors, and not being able to afford consumer goods and/or activities. Some respondents reported seeking to numb these feelings through the use of alcohol or cannabis. Others avoided opening letters or answering telephone calls.In the interviews, foodbank clients expressed their feelings about their situation. Shame was the most frequently mentioned emotion and related to the label of “foodbank client”, the working method of the foodbank or not being able to consume what they wanted to. Firstly, respondents felt ashamed about being a foodbank client, because this is not acceptable in their social and cultural environment, and there is a negative stigma associated with being a foodbank client rather than a “normal working citizen”. Some of the respondents try to hide the fact that they use a foodbank, while others stated that they liked to form friendships with other foodbank clients because they would be more likely to accept and understand them. Another reaction was to downplay the situation. Secondly, shame was connected to the way that the foodbank operates. Clients feel ashamed to have to show their administration in the assessment interview before they can qualify for a food parcel. Shame is also felt when going to the foodbank and as result of the lack of choice of food. Thirdly, we found a category of shame that was related to the restrictions of consumption. The foodbank clients feel that they are unable to buy the food or clothing that they want or to take part in activities.In conclusion, we found, in line with other studies, that foodbank clients experience psychological suffering and feelings of shame. These feelings of shame relate to the stigma attached to being a foodbank client and are reinforced by the way the foodbanks operate. Foodbank clients feel that they have a lack of choice, not only at the foodbank, but also in the wider context of the consumer society. SAMENVATTINGErvaringen van schaamte en psychologisch lijden door voedselbankklanten Voedselbanken bestaan al meer dan tien jaar in Nederland en groeien in aantal en omvang. Er is beperkt wetenschappelijk onderzoek gedaan naar voedselbankklanten in Nederland en ook in internationale studies ontbreekt het klantperspectief. In dit artikel presenteren wij bevindingen uit 45 diepte-interviews met voedselbankklanten in Amsterdam, waarbij wij hun ervaring centraal stelden. De centrale vraag die wij in dit artikel beantwoorden is: welke rol spelen financiële problemen, schaamte en andere emoties bij voedselbankklanten in Amsterdam? Voedselbankklanten zeggen dat zij besparen op consumptiemiddelen en activiteiten vanwege hun gelimiteerde budget. Het gebrek aan geld beperkt een aantal respondenten in hun sociale leven. In reactie op geldzorgen laten sommigen hun post ongeopend of zij verdoven zich. De respondenten uiten dat zij stress, slapeloosheid, angst, paniek, depressie en/of somberheid door geldgebrek ervaren. Dit vatten wij samen als psychologisch lijden. Hiernaast is schaamte een veel genoemde emotie. Ook uit andere studies bleek dat schaamte veel voorkomt bij voedselbankklanten. Wij zagen hiervoor drie verschillende oorzaken: het stempel voedselbankklant, de werkwijze van de voedselbank en het beperkt zijn qua consumptiemogelijkheden. Reacties op de schaamte zijn: relativeren, afstand nemen of juist verbinding zoeken met andere voedselbankklanten. Hiernaast zijn er respondenten die proberen te verbergen dat zij voedselbankklant zijn.
- Published
- 2016
- Full Text
- View/download PDF
26. Etik Dine Nasıl Dayandırılabilir?
- Author
-
Jonathan Berg and Muhammet İrğat
- Subjects
Philosophy. Psychology. Religion ,Religion (General) ,BL1-50 - Published
- 2015
- Full Text
- View/download PDF
27. Multiplex ligation-dependent probe amplification using a completely synthetic probe set
- Author
-
Rowena F. Stern, Roland G. Roberts, Kathy Mann, Shu C. Yau, Jonathan Berg, and Caroline Mackie Ogilvie
- Subjects
Biology (General) ,QH301-705.5 - Abstract
The recent development of multiplex ligation-dependent probe amplification (MLPA) has provided an efficient and reliable assay for dosage screening of multiple loci in a single reaction. However, a drawback to this method is the time-consuming process of generating a probe set by cloning in single-stranded bacteriophage vectors. We have developed a synthetic probe set to screen for deletions in a region spanning 18.5 Mb within chromosome 3q. In a pilot study, we tested 15 synthetic probes on 4 control samples and on 2 patients previously found to possess a heterozygous deletion in the region 3q26–q28. These synthetic probes detected deletions at all previously known deleted loci. Furthermore, using synthetic probes, the variability of results within samples was similar to that reported for commercially available M13-derived probes. Our results demonstrate that this novel approach to MLPA provides a generic solution to the difficulties of probe development by cloning; such synthetically generated probes may be used to screen a large number of loci in a single reaction. We conclude that the use of synthetic probes for MLPA is a rapid, robust, and efficient alternative for research (and potentially diagnostic) deletion and duplication screening of multiple genomic loci.
- Published
- 2004
- Full Text
- View/download PDF
28. The Point of Interpreting Arguments
- Author
-
Jonathan Berg
- Subjects
argument ,interpretation ,intentions ,Logic ,BC1-199 - Abstract
It is wrong to think that questions of interpretation are significant in informal logic only to the extent that they contribute to the assessment of an argument's conclusion. For one thing, logic is essentially about validity, about that in virtue of which conclusions do or do not follow from given premises, and not about the truth or falsity of conclusions by themselves. Secondly, the evaluation of a given argument requires first determining what the given argument is. Moreover, since arguments are given in rational discourse in order to persuade-in order to arrive, by reason, at agreement-it is necessary to address the very arguments that arguers actually intend.
- Published
- 1992
- Full Text
- View/download PDF
29. Interpreting Arguments
- Author
-
Jonathan Berg
- Subjects
Logic ,BC1-199 - Published
- 1987
- Full Text
- View/download PDF
30. Neuropsychiatric risk in children with intellectual disability of genetic origin: IMAGINE, a UK national cohort study
- Author
-
Jeanne Wolstencroft, Francesca Wicks, Ramya Srinivasan, Sarah Wynn, Tamsin Ford, Kate Baker, Samuel J R A Chawner, Jeremy Hall, Marianne B M van den Bree, Michael J Owen, David Skuse, F Lucy Raymond, Marie Erwood, Amy Lafont, Husne Timur, Zheng Ye, Susan Walker, Frida Printzlau, Manoj Juj, Sarah Davies, Hayley Denyer, Alice Watkins, Eleanor Kerry, Nadia Coscini, Nasrtullah Fatih, Anna Lucock, Spiros Denaxas, William Mandy, Neil Walker, Sarah Wallwork, Eleanor Dewhurst, Andrew Cuthbert, Aimee Challenger, Sophie Andrews, Peter Holmans, Samantha Bowen, Karen Bradley, Philippa Birch, Molly Tong, Nicola Lewis, Sinead Ray, Matthew Sopp, Hayley Moss, Beverley Searle, Lisa Robertson, Jonathan Berg, Anne Lampe, Shelagh Joss, Paul Brennan, Alison Kraus, Nayana Lahiri, Astrid Weber, Myfanwy Rawson, Diana Johnson, Pradeep Vasudevan, Rachel Harrison, Denise Williams, Eamonn Maher, Usha Kini, Fleur Van Dijk, Virginia Clowes, Jana Gurasashvilli, Sahar Mansour, Muriel Holder-Espinasse, Amy Watford, Julia Rankin, Diana Baralle, Annie Procter, Samuel Chawner, and Marianne B M Van den Bree
- Subjects
Male ,Adolescent ,Autism Spectrum Disorder ,State Medicine ,United Kingdom ,Cohort Studies ,Psychiatry and Mental health ,Child, Preschool ,Intellectual Disability ,Humans ,Female ,Prospective Studies ,Child ,Biological Psychiatry - Abstract
Background\ud Children with intellectual disability frequently have multiple co-morbid neuropsychiatric conditions and poor physical health. Genomic testing is increasingly recommended as a first-line investigation for these children. We aim to determine the effect of genomics, inheritance, and socioeconomic deprivation on neuropsychiatric risk in children with intellectual disability of genetic origin as compared with the general population.\ud Methods\ud IMAGINE is a prospective cohort study using online mental health and medical assessments in a cohort of 3407 UK participants with intellectual disability and pathogenic genomic variants as identified by the UK's National Health Service (NHS). Our study is on a subset of these participants, including all children aged 4–19 years. We collected diagnostic genomic reports from NHS records and asked primary caregivers to provide an assessment of their child using the Development and Well-Being Assessment (DAWBA), the Strengths and Difficulties Questionnaire (SDQ), the Adaptive Behaviour Assessment System 3 (ABAS-3), and a medical history questionnaire. Each child was assigned a rank based on their postcode using the index of multiple deprivation (IMD). We compared the IMAGINE cohort with the 2017 National Survey of Children's Mental Health in England. The main outcomes of interest were mental health and neurodevelopment according to the DAWBA and SDQ.\ud Findings\ud We recruited 2770 children from the IMAGINE study between Oct 1, 2014 and June 30, 2019, of whom 2397 (86·5%) had a basic assessment of their mental health completed by their families and 1277 (46·1%) completed a medical history questionnaire. The mean age of participants was 9·2 years (SD 3·9); 1339 (55·9%) were boys and 1058 (44·1%) were girls. 355 (27·8%) of 1277 reported a seizure disorder and 814 (63·7%) reported movement or co-ordination problems. 1771 (73·9%) of 2397 participants had a pathogenic copy number variant (CNV) and 626 (26·1%) had a pathogenic single nucleotide variant (SNV). Participants were representative of the socioeconomic spectrum of the UK general population. The relative risk (RR) of co-occurring neuropsychiatric diagnoses, compared with the English national population, was high: autism spectrum disorder RR 29·2 (95% CI 23·9–36·5), ADHD RR 13·5 (95% CI 11·1–16·3). In children with a CNV, those with a familial variant tended to live in more socioeconomically deprived areas than those with a de novo variant. Both inheritance and socioeconomic deprivation contributed to neuropsychiatric risk in those with a CNV.\ud Interpretation\ud Children with genomic variants and intellectual disability are at an increased risk of neuropsychiatric difficulties. CNV variant inheritance and socioeconomic deprivation also contribute to the risk. Early genomic investigations of children with intellectual disability could facilitate the identification of the most vulnerable children. Additionally, harnessing parental expertise using online DAWBA assessments could rapidly identify children with exceptional needs to child mental health services.
- Published
- 2022
31. Mild hypothermia attenuates ischaemia/reperfusion injury: insights from serial non-invasive pressure–volume loops
- Author
-
Jonathan Berg, Robert Jablonowski, David Nordlund, Daniel Ryd, Einar Heiberg, Marcus Carlsson, and Håkan Arheden
- Subjects
Physiology ,Physiology (medical) ,Cardiology and Cardiovascular Medicine - Abstract
AimsMild hypothermia, 32–35°C, reduces infarct size in experimental studies, potentially mediating reperfusion injuries, but human trials have been ambiguous. To elucidate the cardioprotective mechanisms of mild hypothermia, we analysed cardiac performance in a porcine model of ischaemia/reperfusion, with serial cardiovascular magnetic resonance (CMR) imaging throughout 1 week using non-invasive pressure–volume (PV) loops.Methods and resultsNormothermia and Hypothermia group sessions (n = 7 + 7 pigs, non-random allocation) were imaged with Cardiovascular magnetic resonance (CMR) at baseline and subjected to 40 min of normothermic ischaemia by catheter intervention. Thereafter, the Hypothermia group was rapidly cooled (mean 34.5°C) for 5 min before reperfusion. Additional CMR sessions at 2 h, 24 h, and 7 days acquired ventricular volumes and ischaemic injuries (unblinded analysis). Stroke volume (SV: −24%; P = 0.029; Friedmans test) and ejection fraction (EF: −20%; P = 0.068) were notably reduced at 24 h in the Normothermia group compared with baseline. In contrast, the decreases were ameliorated in the Hypothermia group (SV: −6%; P = 0.77; EF: −6%; P = 0.13). Mean arterial pressure remained stable in Normothermic animals (−3%, P = 0.77) but dropped 2 h post-reperfusion in hypothermic animals (−18%, P = 0.007). Both groups experienced a decrease and partial recovery pattern for PV loop-derived variables over 1 week, but the adverse effects tended to attenuate in the Hypothermia group. Infarct sizes were 10 ± 8% in Hypothermic and 15 ± 8% in Normothermic animals (P = 0.32). Analysis of covariance at 24 h indicated that hypothermia has cardioprotective properties incremental to reducing infarct size, such as higher external power (P = 0.061) and lower arterial elastance (P = 0.015).ConclusionUsing non-invasive PV loops by CMR, we observed that mild hypothermia at reperfusion alleviates the heart’s work after ischaemia/reperfusion injuries during the first week and preserves short-term cardiac performance. This hypothesis-generating study suggests hypothermia to have cardioprotective properties, incremental to reducing infarct size. The primary cardioprotective mechanism was likely an afterload reduction acutely unloading the left ventricle.
- Published
- 2023
32. Report – Cost and Clinical Utility of WES and WGS in pediatric patients with suspected genetic disease
- Author
-
Michael P. Douglas, Patricia A. Deverka, Bruce Gelb, Bart Ferket, Kristen Hassmiller Lich, Hadley Stevens Smith, Mary Norton, Jonathan Berg, Anne Slavotinek, Lucia Hindorff, and Kathryn Phillips
- Abstract
Payer coverage for Exome Sequencing (ES) is becoming commonplace (albeit in some cases with prior authorization restrictions), coverage for Genome Sequencing (GS) is rare, with most payers considering it as investigational and not medically necessary. Previous studies had identified several concerns and challenges from the payer perspective.The objective of this study is to conduct a targeted literature review of the evidence describing the cost and clinical utility of GS and ES compared to standard of care (SoC) testing in children ≤18 years with suspected genetic disease.We conducted a systematic literature review to identify evidence for cost, diagnostic utility and clinical utility between SoC, ES, and GS in children (0-18 years) with suspected genetic diseases. We also identified list prices for individual tests from Concert Genetics. Descriptive analyses were conducted for cost and comparative effectiveness data.We identified five studies on costs of ES and GS, as well as data from concert genetics, and 62 studies of comparative effectiveness of GS or ES in pediatric patients There is limited evidence of GS over ES in the ability to effect change in management. Available evidence suggests that rapid over standard GS or ES is of greater benefit in the NICU/PICU setting vs. outpatient setting. Future clinical studies must include both diagnostic yield and clinical management outcomes in order to provide stakeholders with the necessary evidence to support decision-making on implementation and coverage.
- Published
- 2022
33. Characterizing Breast Phenotype with a Novel Measure of Fibroglandular Structure.
- Author
-
John H. Hipwell, Lewis D. Griffin, Patsy J. Whelehan, Wenlong Song, Xiying Zhang, Jan M. Lesniak, Sarah Vinnicombe, Andy Evans, Jonathan Berg, and David J. Hawkes
- Published
- 2012
- Full Text
- View/download PDF
34. Genome sequencing with gene panel-based analysis for rare inherited conditions in a publicly funded healthcare system: implications for future testing
- Author
-
Lynne J, Hocking, Claire, Andrews, Christine, Armstrong, Morad, Ansari, David, Baty, Jonathan, Berg, Therese, Bradley, Caroline, Clark, Austin, Diamond, Jill, Doherty, Anne, Lampe, Ruth, McGowan, David J, Moore, Dawn, O'Sullivan, Andrew, Purvis, Javier, Santoyo-Lopez, Paul, Westwood, Michael, Abbott, Nicola, Williams, Timothy J, Aitman, and Margo, Whiteford
- Subjects
Genetics ,Genetics (clinical) - Abstract
NHS genetics centres in Scotland sought to investigate the Genomics England 100,000 Genomes Project diagnostic utility to evaluate genome sequencing for in rare, inherited conditions. Four regional services recruited 999 individuals from 394 families in 200 rare phenotype categories, with negative historic genetic testing. Genome sequencing was performed at Edinburgh Genomics, and phenotype and sequence data were transferred to Genomics England for variant calling, gene-based filtering and variant prioritisation. NHS Scotland genetics laboratories performed interpretation, validation and reporting. New diagnoses were made in 23% cases – 19% in genes implicated in disease at the time of variant prioritisation, and 4% from later review of additional genes. Diagnostic yield varied considerably between phenotype categories and was minimal in cases with prior exome testing. Genome sequencing with gene panel filtering and reporting achieved improved diagnostic yield over previous historic testing but not over now routine trio-exome sequence tests. Re-interpretation of genomic data with updated gene panels modestly improved diagnostic yield at minimal cost. However, to justify the additional costs of genome vs exome sequencing, efficient methods for analysis of structural variation will be required and / or cost of genome analysis and storage will need to decrease.
- Published
- 2022
35. Information-Seeking Preferences in Diverse Patients Receiving a Genetic Testing Result in the Clinical Sequencing Evidence-Generating Research (CSER) Study
- Author
-
Anne Slavotinek, Hannah Prasad, Simon Outram, Sarah Scollon, Shannon Rego, Tiffany Yip, Hannah Hoban, Kate M. Foreman, Whitley Kelley, Candice Finnila, Jonathan Berg, Priyanka Murali, Katherine E. Bonini, Lisa J. Martin, and Adam Hott
- Subjects
Genetics (clinical) - Published
- 2023
36. Developing a multi-stakeholder intervention for Lynch syndrome cascade screening: an intervention mapping approach
- Author
-
Lauren Passero, Swetha Srinivasan, Mary E Grewe, Jennifer Leeman, Jonathan Berg, Daniel Reuland, and Megan C Roberts
- Abstract
Background Lynch syndrome is an underdiagnosed hereditary condition carrying an increased lifetime risk for colorectal and endometrial cancer and affecting nearly 1 million people in the United States. Cascade screening, systematic screening through family members of affected patients, could improve identification of Lynch syndrome, but this strategy is underused due to multi-level barriers including low knowledge about Lynch syndrome, low access to genetics services, and challenging family dynamics. Methods We used intervention mapping, a 6-step methodology to create stakeholder-driven interventions that meet the needs of a target population, to develop an intervention to improve cascade screening for Lynch syndrome. The intervention development process was guided by input from key stakeholders in Lynch syndrome care and patients. We conducted usability testing on the intervention with Lynch syndrome patients using qualitative semi-structured interviewing and rapid qualitative analysis. Results We developed a workbook intervention named Let’s Talk that addresses gaps in knowledge, skills, self-efficacy, outcome expectancy and other perceived barriers to cascade screening for Lynch syndrome. Let’s Talk contained educational content, goal setting activities, communication planning prompts and supplemental resources for patients to plan family communication. Evidence-based methods used in the workbook included information chunking, guided practice, goal setting and gain-framing. Usability testing results suggested the intervention was acceptable in terms of complexity and relative advantage to other available resources, but additional information for communication with young or distant family members and a web-based platform could enhance the intervention’s usability. Conclusions Intervention mapping provided a framework for intervention development that addressed the unique needs of Lynch syndrome patients in overcoming barriers to cascade screening. Future work is needed to transform Let’s Talk into a web-based tool and evaluate the effectiveness of the intervention in clinical practice with patients and genetic counselors. Intervention mapping can be useful to researchers as an evidence-based technique to develop stakeholder-centered interventions for addressing the needs of other unique populations.
- Published
- 2022
37. Naming, Necessity and More: Explorations in the Philosophical Work of Saul Kripke
- Author
-
Jonathan Berg and Jonathan Berg
- Published
- 2014
38. High-intensity exergaming for improved cardiorespiratory fitness: A randomised, controlled trial
- Author
-
Jonathan Berg, Trine Moholdt, Alf Inge Wang, and Guri Haugen
- Subjects
Adult ,medicine.medical_specialty ,business.industry ,High intensity ,030209 endocrinology & metabolism ,Physical Therapy, Sports Therapy and Rehabilitation ,Cardiorespiratory fitness ,030229 sport sciences ,General Medicine ,Exercise Therapy ,law.invention ,03 medical and health sciences ,0302 clinical medicine ,Cardiorespiratory Fitness ,Randomized controlled trial ,law ,Endurance training ,Physical therapy ,Humans ,Medicine ,Aerobic exercise ,Orthopedics and Sports Medicine ,business ,Exergaming - Abstract
Exergaming has been proposed as a promising alternative to traditional endurance training since many experience exergaming as more enjoyable. Therefore, the aim of this trial was to determine the exergaming-induced effect on cardiorespiratory fitness. This parallel-group randomised controlled trial, investigated the effects of regular exergaming among healthy adults (aged ≥ 18 years) who were not endurance-trained. Participants allocated to the exergaming group (n = 13) used the Playpulse exergaming platform for a minimum of 45 min twice weekly for eight weeks, whereas the control group (n = 17) received no intervention. The primary outcome measure was the between-group difference in peak oxygen uptake (V̇O2peak) after the intervention. V̇O2peak increased significantly from baseline (43.9 [SD 7.0]) to after the intervention (45.3 [SD 8.2] mL kg−1 min−1) in the exergaming group, compared to the control group (42.4 [SD 7.0] to 42.0 [SD 5.7] L·kg−1·min−1) with a between-group difference of 2.1 mL kg−1 min−1 (95% CI: 0.2–4.1; p = 0.04). The average score on the Feeling Scale reported during exergaming was 3.4 (95% CI 3.2–3.6), with 3 being “good” and 5 “very good” and was not related to the participants’ exergaming skills. There were no adverse events during this trial. Two weekly sessions using the Playpulse exergaming platform can improve V̇O2peak. This finding suggests that exergaming can be an efficient form of endurance training. Furthermore, our findings indicate that participants’ enjoyed exergaming irrespective of exergaming skills. Trial registration: ClinicalTrials.gov identifier: NCT04112329
- Published
- 2022
39. Neuropsychiatric Risk in Children With Intellectual Disability of Genetic Origin: IMAGINE - The UK National Cohort Study
- Author
-
Jeanne Wolstencroft, Francesca Wicks, Marie Erwood, ramya srinivasan, Amy Lafont, Husniye Timur, Zheng Ye, susan Walker, Frida Printzlau, Manoj Juj, Sarah Davies, Hayley Denver, Alice Watkins, Eleanor Kerry, Anna Lucock, Nasratullay Fatih, Sarah Wynn, Lisa Robertson, Jonathan Berg, Anne Lampe, Shelagh Joss, paul brennan, alison Kraus, astrid weber, Myfanwy Rawson, diana Johnson, pradeep vasudevan, rachel harrison, denise williams, Eamonn Maher, Usha Kini, Virginia Clowes, Jana Gurasashvili, sahar mansour, muriel Holder-Espinasse, Amy Watford, julia rankin, diana baralle, annie procter, Tamsin Ford, kate baker, Samuel chawners, Jeremy Hall, Marianne van den Bree, Michael Owen, IMAGINE Consortium, David Skuse, and F. Lucy Raymond
- Published
- 2022
40. Designing audio processing strategies to enhance cochlear implant users' music enjoyment
- Author
-
Lloyd May, Aaron Hodges, So Yeon Park, Blair Kaneshiro, and Jonathan Berger
- Subjects
accessibility ,aural diversity ,music personalization ,cochlear implant ,music appreciation ,disability ,Electronic computers. Computer science ,QA75.5-76.95 - Abstract
Cochlear implants (CIs) provide hundreds of thousands of users with increased access to sound, particularly speech, but experiences of music are more varied. Can greater engagement by CI users in the music mixing process mutually benefit them as well as audio engineers? This paper presents an exploratory mixed-methods study that leverages insights from CI users and professional audio engineers (AEs) in the investigation of techniques to enhance CI user music enjoyment and promote empathetic practices in AEs. Analysis of data collected over a multi-step process of surveys, interviews, and iterative cycles of sound mixing and feedback revealed two mixing strategies—namely essentializing and exaggeration of musical elements—common among mixes preferred by CI users. Participant responses also highlighted systemic ableism and audism in the music industry—an industry from which CI users report feeling excluded. Specifically, AEs felt inadequately trained around aural diversity considerations and experienced anxiety around their own aural diversity. In sum, this work contributes to insights into CI user music listening preferences; how AEs approach mixing for an aurally diverse audience; and discussion around the efficacy of CI simulation, user feedback, and AE peer feedback on mix enjoyment by CI users. Based on these findings, we offer several design insights that emphasize the need for customizable music listening tools centered around user agency and enjoyment.
- Published
- 2024
- Full Text
- View/download PDF
41. Decreased atrioventricular plane displacement after acute myocardial infarction yields a concomitant decrease in stroke volume
- Author
-
David Nordlund, Christos G. Xanthis, Kristian Solem, Håkan Arheden, Sebastian Bidhult, Jonathan Berg, Marcus Carlsson, Maythem Saeed, Sascha Kopic, and Robert Jablonowski
- Subjects
medicine.medical_specialty ,AVPD ,Swine ,Physiology ,Myocardial Infarction ,Contrast Media ,Magnetic Resonance Imaging, Cine ,Gadolinium ,030204 cardiovascular system & hematology ,ischemia-reperfusion ,030218 nuclear medicine & medical imaging ,AMI ,03 medical and health sciences ,0302 clinical medicine ,Animal model ,Physiology (medical) ,Internal medicine ,medicine ,Animals ,Displacement (orthopedic surgery) ,cardiovascular diseases ,Myocardial infarction ,business.industry ,animal model ,Heart ,Stroke Volume ,Stroke volume ,medicine.disease ,Concomitant ,cardiac failure ,cardiovascular system ,Cardiology ,business ,Research Article - Abstract
Acute myocardial infarction (AMI) can progress to heart failure, which has a poor prognosis. Normally, 60% of stroke volume (SV) is attributed to the longitudinal ventricular shortening and lengthening evident in the atrioventricular plane displacement (AVPD) during the cardiac cycle, but there is no information on how the relationship changes between SV and AVPD before and after AMI. Therefore, the aim of this study was to determine how SV depends on AVPD before and after AMI in two swine models. Serial cardiac magnetic resonance imaging was carried out before and 1–2 h after AMI in a microembolization model ( n = 12) and an ischemia-reperfusion model ( n = 14). A subset of pigs ( n = 7) were additionally imaged at 24 h and at 7 days. Cine and late gadolinium enhancement images were analyzed for cardiac function, AVPD measurements and infarct size estimation, respectively. AVPD decreased ( P < 0.05) in all myocardial regions after AMI, with a concomitant SV decrease ( P < 0.001). The ischemia-reperfusion model affected SV to a higher degree and had a larger AVPD decrease than the microembolization model (−29 ± 14% vs. −15 ± 18%; P < 0.05). Wall thickening decreased in infarcted areas ( P < 0.001), and A-wave AVPD remained unchanged ( P = 0.93) whereas E-wave AVPD decreased ( P < 0.001) after AMI. We conclude that AVPD is coupled to SV independent of infarct type but likely to a greater degree in ischemia-reperfusion infarcts compared with microembolization infarcts. AMI reduces diastolic early filling AVPD but not AVPD from atrial contraction. These findings shed light on the physiological significance of atrioventricular plane motion when assessing acute and subacute myocardial infarction. NEW & NOTEWORTHY The link between cardiac longitudinal motion, measured as atrioventricular plane displacement (AVPD), and stroke volume (SV) is investigated in swine after acute myocardial infarction (AMI). This cardiac magnetic resonance study demonstrates a close coupling between AVPD and SV before and after AMI in an experimental setting and demonstrates that this connection is present in ischemia-reperfusion and microembolization infarcts, acutely and during the first week. Furthermore, AVPD is equally and persistently depressed in infarcted and remote myocardium after AMI.
- Published
- 2020
42. Abstract 14088: Ventricular Longitudinal Function by CMR Predicts Heart Failure Associated Morbidity in Patients With Heart Failure and Reduced Ejection Fraction
- Author
-
Jonathan Berg, Julius Åkesson, Robert Jablonowski, Kristian Solem, Einar Heiberg, Rasmus Borgquist, Håkan Arheden, and Marcus Carlsson
- Subjects
Physiology (medical) ,Cardiology and Cardiovascular Medicine - Abstract
Ventricular longitudinal function measured as basal-apical atrioventricular plane displacement (AVPD) or global longitudinal strain (GLS) are potent predictors of mortality and could potentially be predictors of morbidity in heart failure (HF). We hypothesize that decreased AVPD and GLS are associated with increased morbidity measured. Patients with HFrEF (EF≤40%) referred to a CMR exam were considered for inclusion. Ventricular longitudinal function, ventricular volumes and myocardial fibrosis or infarctions were analyzed. National registries provided data on cause of cardiovascular hospitalizations and cardiovascular mortality and this was used as a composite endpoint. A time-to-event analysis capable of including reoccurring events were employed with 5-year follow-up. HFrEF patients (n=287, age 62±12, 78% male) had EF 26.5% (SEM 0.5), AVPD 7.8 mm (SEM 0.1) and GLS -7.5% (SEM 0.2). There were 578 events in total and the vast majority was HF hospitalizations (n=418). Other major events were revascularizations (n=64), cardiovascular deaths (n=40) and myocardial infarctions (n=21), and 155 (54%) patients experienced at least one event (Mean 2.0, range 0-64). Patients in the bottom AVPD or GLS tertile (-6.1%) experienced over 3 times as many events compared to the top tertile (>8.8 mm or
- Published
- 2021
43. OTH-4 Assessing the effectiveness of current UK guidelines on familial colorectal cancer risk
- Author
-
Jacqueline Dunlop, James Cotton, Jonathan Berg, Richard Oparka, and Kyriaki Christou
- Subjects
Oncology ,medicine.medical_specialty ,Colorectal cancer ,business.industry ,Internal medicine ,medicine ,Current (fluid) ,medicine.disease ,business - Published
- 2021
44. Direct Belief
- Author
-
Jonathan Berg and Jonathan Berg
- Published
- 2012
45. eP055: The Clinical Genome Resource (ClinGen) Somatic Cancer Clinical Domain Working Group
- Author
-
Jason Saliba, Gordana Raca, Angshumoy Roy, Ian King, Shamini Selvarajah, Xinjie Xu, Rashmi Kanagal-Shamana, Laveniya Satgunaseelan, David Meredith, Mark Evans, Alanna Church, Panieh Terraf, Yassmine Akkari, Heather Williams, Wan-Hsin Lin, Chimene Kesserwan, Deborah Ritter, Kilannin Krysiak, Arpad Danos, Alex Wagner, Marilyn Li, Dmitriy Sonkin, Jonathan Berg, Sharon Plon, Heidi Rehm, Shashikant Kulkarni, Ramaswamy Govindan, Obi Griffith, and Malachi Griffith
- Subjects
Genetics (clinical) - Published
- 2022
46. eP354: A systematic approach for applying disease-specific phenotype in clinical variant interpretation
- Author
-
Emily Groopman, Jennifer Goldstein, Shannon McNulty, Justyne Ross, Kelsea Chang, Steven Harrison, and Jonathan Berg
- Subjects
Genetics (clinical) - Published
- 2022
47. Ventricular longitudinal shortening is an independent predictor of death in heart failure patients with reduced ejection fraction
- Author
-
Jonathan Berg, M Carlsson, Rasmus Borgquist, Robert Jablonowski, Moman A. Mohammad, Håkan Arheden, K. Solem, and Ellen Ostenfeld
- Subjects
Male ,medicine.medical_specialty ,Heart disease ,Epidemiology ,Science ,Heart Ventricles ,Magnetic Resonance Imaging, Cine ,Heart failure ,Kaplan-Meier Estimate ,Spironolactone ,Risk Assessment ,Article ,Body Mass Index ,Cicatrix ,Ventricular Dysfunction, Left ,Prognostic markers ,Risk Factors ,Internal medicine ,medicine ,Humans ,Diuretics ,Cause of death ,Aged ,Proportional Hazards Models ,Univariate analysis ,Multidisciplinary ,Ejection fraction ,Aspirin ,business.industry ,Hazard ratio ,Stroke Volume ,Middle Aged ,medicine.disease ,Prognosis ,Fibrosis ,Treatment Outcome ,Outcomes research ,Cardiology ,Etiology ,Medicine ,Female ,business ,Follow-Up Studies - Abstract
Reduced ventricular longitudinal shortening measured by atrioventricular plane displacement (AVPD) and global longitudinal strain (GLS) are prognostic markers in heart disease. This study aims to determine if AVPD and GLS with cardiovascular magnetic resonance (CMR) are independent predictors of cardiovascular (CV) and all-cause death also in heart failure with reduced ejection fraction (HFrEF). Patients (n = 287) were examined with CMR and AVPD, GLS, ventricular volumes, myocardial fibrosis/scar were measured. Follow-up was 5 years with cause of death retrieved from a national registry. Forty CV and 60 all-cause deaths occurred and CV non-survivors had a lower AVPD (6.4 ± 2.0 vs 8.0 ± 2.4 mm, p
- Published
- 2021
48. Comparison of Physiological and Perceptual Responses to Upper-, Lower-, and Whole-Body Exercise in Elite Cross-Country Skiers
- Author
-
Jonathan Berg, Øyvind Sandbakk, Vidar Undebakke, and Arnt Erik Tjønna
- Subjects
Adult ,Male ,medicine.medical_specialty ,Physical Exertion ,Physical Therapy, Sports Therapy and Rehabilitation ,030204 cardiovascular system & hematology ,Running ,Upper Extremity ,Random Allocation ,Young Adult ,03 medical and health sciences ,Oxygen Consumption ,0302 clinical medicine ,Heart Rate ,Skiing ,Endurance training ,Internal medicine ,Heart rate ,medicine ,Humans ,Orthopedics and Sports Medicine ,Lactic Acid ,Exercise physiology ,Exercise ,Mathematics ,Rating of perceived exertion ,Cross country ,Work (physics) ,VO2 max ,Cardiorespiratory fitness ,030229 sport sciences ,General Medicine ,Lower Extremity ,Exercise Test ,Physical Endurance ,Cardiology - Abstract
Undebakke, V, Berg, J, Tjønna, AE, and Sandbakk, Ø. Comparison of physiological and perceptual responses to upper-, lower-, and whole-body exercise in elite cross-country skiers. J Strength Cond Res 33(4): 1086–1094, 2019—The primary purpose of the present study was to compare physiological and perceptual responses to maximal and submaximal exercise between upper-, lower-, and whole-body exercise modes in elite cross-country (XC) skiers. Twelve elite XC skiers performed 5–7 submaximal 5-minute stages and an incremental test to exhaustion using upper-body poling (UP), running (RUN), and diagonal skiing (DIA), randomized on 3 separate days. Here, power output, cardiorespiratory variables, heart rate (HR), blood lactate concentration (BLa), and rating of perceived exertion (RPE) were determined. Peak power output increased gradually from UP to RUN and DIA, whereas peak oxygen uptake (V[Combining Dot Above]O2peak), peak HR, O2pulse, and total RPE were clearly lower in UP than RUN and DIA (p < 0.05). At submaximal workloads matched for either RPE, %HR, or BLa, the main pattern was that BLa was higher and V[Combining Dot Above]O2 and HR lower in UP compared with RUN and DIA (p < 0.05). DIA showed ∼10 and 35% higher V[Combining Dot Above]O2 than RUN and UP at RPE 10–13 and had lower muscular RPE values than UP and RUN at a given % of peak HR (p < 0.05). Most of the differences in cardiorespiratory variables between modes were eliminated when they were normalized to V[Combining Dot Above]O2peak or peak HR in the respective mode. Because of the low power production in UP, endurance training in this mode exhibits too low values of V[Combining Dot Above]O2 to tax the cardiovascular system sufficiently. In RUN and DIA, the similar V[Combining Dot Above]O2peak values indicate that both modes can be effectively used during high-intensity training and to determine V[Combining Dot Above]O2max in elite XC skiers. However, the relatively high V[Combining Dot Above]O2 values at low perceptual stress with submaximal DIA indicate that the large amount of power produced when combining upper- and lower-body work exhibits high oxidative flux even during low-intensity training. Overall, these findings should be taken into account when athletes and coaches are monitoring and prescribing training in future approaches, in particular in sports where athletes vary between training with upper-, lower-, and whole-body exercise modes. © 2019. This is the authors' accepted and refereed manuscript to the chapter. Locked until 30.4.2020 due to copyright restrictions. The final authenticated version is available online at: 10.1519/JSC.0000000000003078
- Published
- 2019
49. Missense Variants in the Histone Acetyltransferase Complex Component Gene TRRAP Cause Autism and Syndromic Intellectual Disability
- Author
-
Philippe M. Campeau, Katherine Agre, Vernon R. Sutton, Kirsty McWalter, Bertrand Isidor, Øystein L. Holla, Anna Lehman, Megha Desai, Jonathan Berg, Stéphane Bézieau, Rolph Pfundt, Jennifer Tarpinian, Jennifer B. Humberson, Holly A.F. Stessman, Madeleine R. Geisheker, Emma Bedoukian, Shalini N. Jhangiani, Marine I. Murphree, Annapurna Poduri, Anne-Sophie Denommé-Pichon, Christian Gilissen, Yaping Yang, Eliane Beauregard-Lacroix, Claude Férec, Francesca Filippini, Anne Guimier, Daryl A. Scott, Stephen Sanders, Julie C. Sapp, Ralitza H. Gavrilova, Slavé Petrovski, Ann Nordgren, Sylvia Redon, Ernie M.H.F. Bongers, Shelagh Joss, Jill A. Rosenfeld, Wallid Deb, Ingrid M. Wentzensen, Usha Kini, Vandana Shashi, Mindy H. Li, Stanislas Lyonnet, Thomas Garcia, Øyvind L. Busk, Christoffer Nellåker, Amber Begtrup, Brigitte Gilbert-Dussardier, Thomas Besnard, Francois V. Bolduc, Patrick R. Blackburn, Justine Rousseau, Frédéric Bilan, Eric W. Klee, Christopher T. Gordon, Pavel N. Pichurin, Peggy Kulch, Kevin P. Lally, Laurie Robak, Arnaud Picard, Kristian Tveten, Meredith Park, Sébastien Küry, Jaya Punetha, Moira Blyth, Asbjørg Stray-Pedersen, Jacqueline Harris, Erin L. Heinzen, Nicholas Stong, Cara M. Skraban, Julie S. Cohen, Aida Telegrafi, Xenia Latypova, Zeynep Coban Akdemir, Jacob Zyskind, Caitlin Troyer, Xiang-Jiao Yang, Tuula Rinne, Leslie G. Biesecker, Jennifer E. Posey, Kyle Retterer, Jeanne Amiel, Rui Xiao, Magnus Nordenskjöld, Tammie Dewan, Jennifer A. Sullivan, Charlotte von der Lippe, Evan E. Eichler, Anna Lindstrand, Dominique Bonneau, Yuri A. Zarate, Elaine H. Zackai, Fayth M. Kalb, Daniel H. Lowenstein, Shiri Avni, Benjamin Cogné, Jennifer J. Johnston, Kerri H. Whitlock, Catherine Shain, Séverine Audebert-Bellanger, Malin Kvarnung, Oana Caluseriu, David Goldstein, Annick Toutain, Andres Hernandez-Garcia, Brina Daniels, Sophie Ehresmann, James R. Lupski, Julie McGaughran, Ashley H Ebanks, Kévin Uguen, Marine Legendre, Sylvie Odent, Richard Redon, Erica H. Gerkes, Xiaofei Song, unité de recherche de l'institut du thorax UMR1087 UMR6291 (ITX), Université de Nantes - UFR de Médecine et des Techniques Médicales (UFR MEDECINE), Université de Nantes (UN)-Université de Nantes (UN)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Centre hospitalier universitaire de Nantes (CHU Nantes), CHU Sainte Justine [Montréal], Université du Québec à Montréal = University of Québec in Montréal (UQAM), University of Oxford [Oxford], GeneDx [Gaithersburg, MD, USA], Mayo Clinic [Rochester], University of California [San Francisco] (UCSF), University of California, Génétique, génomique fonctionnelle et biotechnologies (UMR 1078) (GGB), Institut Brestois Santé Agro Matière (IBSAM), Université de Brest (UBO)-Université de Brest (UBO)-EFS-Institut National de la Santé et de la Recherche Médicale (INSERM), Etablissement Français du Sang Bretagne, EFS, Hôpital de la Cavale Blanche - CHRU Brest (CHU - BREST ), Johns Hopkins University School of Medicine [Baltimore], Kennedy Krieger Institute [Baltimore], Chapel Allerton Hospital, University of British Columbia (UBC), University of Dundee, Rush University Medical Center [Chicago], Oxford University Hospitals NHS Trust, Queen Elizabeth University Hospital (Glasgow), Trondheim University, Imagine - Institut des maladies génétiques (IHU) (Imagine - U1163), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Paris (UP), University of Virginia [Charlottesville], Texas Children's Hospital [Houston, USA], Baylor College of Medicine (BCM), Baylor University, University of Pennsylvania [Philadelphia], National Human Genome Research Institute (NHGRI), Harvard Medical School [Boston] (HMS), Karolinska University Hospital [Stockholm], Duke University Medical Center, University of Groningen [Groningen], University of Arkansas for Medical Sciences (UAMS), McGovern Medical School [Houston, Texas], The University of Texas Health Science Center at Houston (UTHealth), Phoenix Children's Hospital, Columbia University [New York], University of Southern Queensland (USQ), Telemark Hospital Trust [Skien, Norway], University of Washington [Seattle], Oslo University Hospital [Oslo], Children’s Hospital of Philadelphia (CHOP ), CHU Necker - Enfants Malades [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Radboud University Medical Center [Nijmegen], Ann & Robert H. Lurie Children's Hospital of Chicago, Imagerie et cerveau (iBrain - Inserm U1253 - UNIV Tours ), Université de Tours-Institut National de la Santé et de la Recherche Médicale (INSERM), CHU Trousseau [Tours], Centre Hospitalier Régional Universitaire de Tours (CHRU Tours), Institut de Génétique et Développement de Rennes (IGDR), Structure Fédérative de Recherche en Biologie et Santé de Rennes ( Biosit : Biologie - Santé - Innovation Technologique )-Centre National de la Recherche Scientifique (CNRS)-Université de Rennes 1 (UR1), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES), CHU Pontchaillou [Rennes], Centre de référence Maladies Rares CLAD-Ouest [Rennes], Physiopathologie Cardiovasculaire et Mitochondriale (MITOVASC), Université d'Angers (UA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Centre Hospitalier Universitaire d'Angers (CHU Angers), PRES Université Nantes Angers Le Mans (UNAM), Centre Hospitalier Régional Universitaire de Brest (CHRU Brest), Centre hospitalier universitaire de Poitiers (CHU Poitiers), University of Alberta, Boston Children's Hospital, McGill University Health Center [Montreal] (MUHC), Hôpital Morvan - CHRU de Brest (CHU - BREST ), Creighton University Medical School [Omaha, NE, USA], Howard Hughes Medical Institute [Boston] (HHMI), Howard Hughes Medical Institute (HHMI)-Harvard Medical School [Boston] (HMS), National Institute of Neurological Disorders and Stroke, K08 HG008986, National Human Genome Research Institute, BC Children’s Hospital Foundation, Genome British Columbia, Fonds de Recherche du Québec - Santé, Canadian Institutes of Health Research, Center for Individualized Medicine, Mayo Clinic, Health Regional Agency from Poitou-Charentes, French Ministry of Health, RC14_0107, HUGODIMS, NS053998, The Epilepsy Phenome/Genome Project, NS077303, Epi4K, Duke Genome Sequencing Clinic, NINDS R35 NS105078, National Institutes of Health/Eunice Kennedy Shriver National Institute of Child Health and Human Development, HG200328 12, intramural research program of the NHGRI, Dart NeuroScience, Kids Brain Health Network, Mining for Miracles, UM1 HG006542, National Heart, Lung, and Blood Institute, CIM Investigative and Functional Genomics Program, R01MH101221, National Institute of Mental Health, Unité de recherche de l'institut du thorax (ITX-lab), Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université de Nantes - UFR de Médecine et des Techniques Médicales (UFR MEDECINE), Université de Nantes (UN)-Université de Nantes (UN), University of Oxford, University of California [San Francisco] (UC San Francisco), University of California (UC), EFS-Université de Brest (UBO)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut Brestois Santé Agro Matière (IBSAM), Université de Brest (UBO), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPCité), University of Virginia, University of Pennsylvania, Université de Tours (UT)-Institut National de la Santé et de la Recherche Médicale (INSERM), Université de Rennes (UR)-Centre National de la Recherche Scientifique (CNRS)-Structure Fédérative de Recherche en Biologie et Santé de Rennes ( Biosit : Biologie - Santé - Innovation Technologique ), MitoVasc - Physiopathologie Cardiovasculaire et Mitochondriale (MITOVASC), CCSD, Accord Elsevier, Faculteit Medische Wetenschappen/UMCG, Université de Rennes 1 (UR1), and Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-Centre National de la Recherche Scientifique (CNRS)-Structure Fédérative de Recherche en Biologie et Santé de Rennes ( Biosit : Biologie - Santé - Innovation Technologique )
- Subjects
CHROMATIN ,Male ,0301 basic medicine ,Autism ,Sequence Homology ,[SDV.GEN] Life Sciences [q-bio]/Genetics ,Medical and Health Sciences ,0302 clinical medicine ,SCHIZOPHRENIA ,Gene expression ,2.1 Biological and endogenous factors ,Missense mutation ,Aetiology ,Child ,de novo variants ,Genetics (clinical) ,Pediatric ,Genetics & Heredity ,Genetics ,biology ,neurodevelopmental disorders ,histone acetylation ,Adaptor Proteins ,Nuclear Proteins ,Metabolic Disorders Radboud Institute for Molecular Life Sciences [Radboudumc 6] ,Syndrome ,Biological Sciences ,Prognosis ,Phenotype ,Chromatin ,Mental Health ,Histone ,intellectual disability ,Child, Preschool ,Female ,REGULATOR ,congenital malformations ,Rare cancers Radboud Institute for Health Sciences [Radboudumc 9] ,BRAIN-DEVELOPMENT ,Adult ,Adolescent ,Histone acetyltransferase complex ,Intellectual and Developmental Disabilities (IDD) ,Mutation, Missense ,Deciphering Developmental Disorders study ,autism spectrum disorder ,KAT6B ,RNAI SCREEN ,Young Adult ,03 medical and health sciences ,CAUSES Study ,Rare Diseases ,Intellectual Disability ,Report ,COFACTOR ,medicine ,RUBINSTEIN-TAYBI-SYNDROME ,Humans ,Amino Acid Sequence ,Autistic Disorder ,Preschool ,Gene ,Genetic Association Studies ,Adaptor Proteins, Signal Transducing ,[SDV.GEN]Life Sciences [q-bio]/Genetics ,Neurodevelopmental disorders Donders Center for Medical Neuroscience [Radboudumc 7] ,Rubinstein–Taybi syndrome ,Signal Transducing ,Neurosciences ,Infant ,medicine.disease ,TRRAP ,Brain Disorders ,SELF-RENEWAL ,030104 developmental biology ,DE-NOVO MUTATIONS ,Mutation ,biology.protein ,Missense ,030217 neurology & neurosurgery - Abstract
Contains fulltext : 202928.pdf (Publisher’s version ) (Open Access) Acetylation of the lysine residues in histones and other DNA-binding proteins plays a major role in regulation of eukaryotic gene expression. This process is controlled by histone acetyltransferases (HATs/KATs) found in multiprotein complexes that are recruited to chromatin by the scaffolding subunit transformation/transcription domain-associated protein (TRRAP). TRRAP is evolutionarily conserved and is among the top five genes intolerant to missense variation. Through an international collaboration, 17 distinct de novo or apparently de novo variants were identified in TRRAP in 24 individuals. A strong genotype-phenotype correlation was observed with two distinct clinical spectra. The first is a complex, multi-systemic syndrome associated with various malformations of the brain, heart, kidneys, and genitourinary system and characterized by a wide range of intellectual functioning; a number of affected individuals have intellectual disability (ID) and markedly impaired basic life functions. Individuals with this phenotype had missense variants clustering around the c.3127G>A p.(Ala1043Thr) variant identified in five individuals. The second spectrum manifested with autism spectrum disorder (ASD) and/or ID and epilepsy. Facial dysmorphism was seen in both groups and included upslanted palpebral fissures, epicanthus, telecanthus, a wide nasal bridge and ridge, a broad and smooth philtrum, and a thin upper lip. RNA sequencing analysis of skin fibroblasts derived from affected individuals skin fibroblasts showed significant changes in the expression of several genes implicated in neuronal function and ion transport. Thus, we describe here the clinical spectrum associated with TRRAP pathogenic missense variants, and we suggest a genotype-phenotype correlation useful for clinical evaluation of the pathogenicity of the variants.
- Published
- 2019
50. De novo and biallelic DEAF1 variants cause a phenotypic spectrum
- Author
-
Elysa J. Marco, Heather C Mefford, Stacey McGee, Christèle Dubourg, Edmund Cauley, Randi J Hagerman, Maria J. Nabais Sá, Bert B.A. de Vries, Rüdiger Lorenz, Elizabeth E. Palmer, Michael J. Parker, Arjan P.M. de Brouwer, Hester Y. Kroes, M. Chiara Manzini, Abbey A. Scott, Tara Montgomery, Naama Orenstein, Jeanne Amiel, Delphine Héron, Leonie A. Menke, Jonathan Berg, Sylvie Odent, Rachel Harrison, Philip J. Jensik, Rani Sachdev, Miranda Splitt, Tyler Mark Pierson, Jan Maarten Cobben, Ehsan Ghayoor Karimiani, Anneke T. Vulto-vanSilfhout, Roberto Colombo, Nayana Lahiri, Julian A. Martinez-Agosto, Evan P. McNeil, Boris Keren, John M. Graham, Chanika Phornphutkul, Reza Maroofian, Radboud University Medical Center [Nijmegen], Southern Illinois University [Carbondale] (SIU), Sheffield Clinical Genetics Service, Sheffield Children's NHS Foundation Trust, St George's, University of London, Geisel School of Medicine at Dartmouth, University Medical Center [Utrecht], University of California [Davis] (UC Davis), University of California, Nottingham University Hospitals NHS Trust, Northern Genetics Service, Newcastle University [Newcastle], University of New South Wales [Sydney] (UNSW), Department of Pediatrics [Seattle, WA, USA] (Division of Genetic Medicine), University of Washington [Seattle]-Seattle Children’s Hospital, University of California [Los Angeles] (UCLA), Tel Aviv University [Tel Aviv], University of Dundee, Imagine - Institut des maladies génétiques (IMAGINE - U1163), Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM), Service de Génétique Cytogénétique et Embryologie [CHU Pitié-Salpêtrière], CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), University of Amsterdam [Amsterdam] (UvA), Cedars-Sinai Medical Center, The George Washington University (GW), Fondazione 'Policlinico Universitario A. Gemelli' [Rome], CHU Pontchaillou [Rennes], Institut de Génétique et Développement de Rennes (IGDR), Université de Rennes 1 (UR1), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-Centre National de la Recherche Scientifique (CNRS)-Structure Fédérative de Recherche en Biologie et Santé de Rennes ( Biosit : Biologie - Santé - Innovation Technologique ), Warren Alpert Medical School of Brown University, University of California (UC), Nottingham University Hospitals NHS Trust (NUH), Department of Pediatrics [Seattle, WA, USA], Tel Aviv University (TAU), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Université de Rennes (UR)-Centre National de la Recherche Scientifique (CNRS)-Structure Fédérative de Recherche en Biologie et Santé de Rennes ( Biosit : Biologie - Santé - Innovation Technologique ), General Paediatrics, Paediatric Genetics, Amsterdam Reproduction & Development (AR&D), Sheffield Children's Hospital, St George‘s, University of London, University of Washington [Seattle]-Seattle Children’s Hospital [Seattle, WA, USA], Centre National de la Recherche Scientifique (CNRS)-Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM), Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-CHU Pitié-Salpêtrière [APHP], George Washington University (GW), and AMS - Sports
- Subjects
Adult ,Male ,Microcephaly ,Adolescent ,phenotype ,Developmental Disabilities ,genotype ,[SDV]Life Sciences [q-bio] ,Mutation, Missense ,Biology ,Young Adult ,03 medical and health sciences ,Neurodevelopmental disorder ,All institutes and research themes of the Radboud University Medical Center ,Genotype ,medicine ,Humans ,Exome ,Language Development Disorders ,Autistic Disorder ,Allele ,Child ,Alleles ,Genetic Association Studies ,Genetics (clinical) ,030304 developmental biology ,Genetics ,0303 health sciences ,Neurodevelopmental disorders Donders Center for Medical Neuroscience [Radboudumc 7] ,030305 genetics & heredity ,medicine.disease ,Phenotype ,neurodevelopmental disorder ,Human genetics ,DEAF1 ,DNA-Binding Proteins ,intellectual disability ,Child, Preschool ,Speech delay ,Autism ,Female ,medicine.symptom ,Transcription Factors - Abstract
International audience; Purpose To investigate the effect of different DEAF1 variants on the phenotype of patients with autosomal dominant and recessive inheritance patterns and on DEAF1 activity in vitro. Methods We assembled a cohort of 23 patients with de novo and biallelic DEAF1 variants, described the genotype–phenotype correlation, and investigated the differential effect of de novo and recessive variants on transcription assays using DEAF1 and Eif4g3 promoter luciferase constructs. Results The proportion of the most prevalent phenotypic features, including intellectual disability, speech delay, motor delay, autism, sleep disturbances, and a high pain threshold, were not significantly different in patients with biallelic and pathogenic de novo DEAF1 variants. However, microcephaly was exclusively observed in patients with recessive variants (p < 0.0001). Conclusion We propose that different variants in the DEAF1 gene result in a phenotypic spectrum centered around neurodevelopmental delay. While a pathogenic de novo dominant variant would also incapacitate the product of the wild-type allele and result in a dominant-negative effect, a combination of two recessive variants would result in a partial loss of function. Because the clinical picture can be nonspecific, detailed phenotype information, segregation, and functional analysis are fundamental to determine the pathogenicity of novel variants and to improve the care of these patients. © 2019, American College of Medical Genetics and Genomics.
- Published
- 2019
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.